secwatch / observer
8-K filed September 28, 2021, 7:59 PM ET ticker LTBR CIK 0001084554
leadership confidence high sentiment positive materiality 0.30

Lightbridge appoints two independent directors, forms ESG committee

LIGHTBRIDGE Corp

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mark Tobin

Director
LTBR · LIGHTBRIDGE Corp
Effective
2021-09-27
Filed
September 28, 2021, 7:59 PM ET
On September 27, 2021, the Board of Directors (the “Board”) of Lightbridge Corporation (the “Company”) appointed Dr. Sweta Chakraborty and Mr. Mark Tobin as members of the Board.
Appointed

Dr. Sweta Chakraborty

Director
LTBR · LIGHTBRIDGE Corp
Effective
2021-09-27
Filed
September 28, 2021, 7:59 PM ET
On September 27, 2021, the Board of Directors (the “Board”) of Lightbridge Corporation (the “Company”) appointed Dr. Sweta Chakraborty and Mr. Mark Tobin as members of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Tobin was appointed as Director at LIGHTBRIDGE Corp.

Action
appointed
Role
Director
Exact text from the filing
On September 27, 2021, the Board of Directors (the “Board”) of Lightbridge Corporation (the “Company”) appointed Dr. Sweta Chakraborty and Mr. Mark Tobin as members of the Board.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Sweta Chakraborty was appointed as Director at LIGHTBRIDGE Corp.

Action
appointed
Role
Director
Exact text from the filing
On September 27, 2021, the Board of Directors (the “Board”) of Lightbridge Corporation (the “Company”) appointed Dr. Sweta Chakraborty and Mr. Mark Tobin as members of the Board.
View on SEC.gov

LIGHTBRIDGE Corp filing history →

Source: SEC EDGAR
accession 0001477932-21-006800
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.